BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26177007)

  • 21. One year outcome in first episode psychosis: influence of DUP and other predictors.
    Malla AK; Norman RM; Manchanda R; Ahmed MR; Scholten D; Harricharan R; Cortese L; Takhar J
    Schizophr Res; 2002 Apr; 54(3):231-42. PubMed ID: 11950548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of pathways to care among young adults with early psychosis entering a coordinated specialty care program.
    Marino L; Scodes J; Ngo H; Nossel I; Bello I; Wall M; Dixon L
    Early Interv Psychiatry; 2020 Oct; 14(5):544-552. PubMed ID: 31502409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [First Episode Psychosis: Relationship of Symptoms, Initial Treatment and Clinical Response].
    Yıldızhan E; Türkcan A; İnan S; Erenkuş Z; Yalçın Ö; Erdoğan A
    Turk Psikiyatri Derg; 2015; 26(2):77-86. PubMed ID: 26111283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using dimensionality-reduction techniques to understand the organization of psychotic symptoms in persistent psychotic illness and first episode psychosis.
    Fleming LM; Lemonde AC; Benrimoh D; Gold JM; Taylor JR; Malla A; Joober R; Iyer SN; Lepage M; Shah J; Corlett PR
    Sci Rep; 2023 Mar; 13(1):4841. PubMed ID: 36964175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of metacognitive beliefs in the proneness to hallucinations and delusions: an analysis across clinical and non-clinical populations.
    Goldstone E; Farhall J; Thomas N; Ong B
    Br J Clin Psychol; 2013 Sep; 52(3):330-46. PubMed ID: 23865408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia.
    Ohtani T; Bouix S; Lyall AE; Hosokawa T; Saito Y; Melonakos E; Westin CF; Seidman LJ; Goldstein J; Mesholam-Gately R; Petryshen T; Wojcik J; Kubicki M
    Cortex; 2015 Oct; 71():264-76. PubMed ID: 26277547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of untreated psychosis and negative symptoms--a systematic review and meta-analysis of individual patient data.
    Boonstra N; Klaassen R; Sytema S; Marshall M; De Haan L; Wunderink L; Wiersma D
    Schizophr Res; 2012 Dec; 142(1-3):12-9. PubMed ID: 23025994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sociodemographic and clinical correlates of hallucinations in patients entering an early intervention program for first episode psychosis.
    Aversa S; Ghanem J; Grunfeld G; Lemonde AC; Malla A; Iyer S; Joober R; Lepage M; Shah J
    Schizophr Res; 2024 Jul; 269():86-92. PubMed ID: 38754313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS).
    Nkire N; Scully PJ; Browne DJ; Baldwin PA; Kingston T; Owoeye O; Kinsella A; O'Callaghan E; Russell V; Waddington JL
    Eur Neuropsychopharmacol; 2021 Jun; 47():20-30. PubMed ID: 33823369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and Differences in Associations Between Duration of Untreated Psychosis (DUP) and Demographic, Premorbid, and Symptom Severity Measures in Two Samples of First-Episode Psychosis Patients from Mexico and the United States.
    Fresan A; Apiquian R; Robles-García R; Zarate CT; Balducci PM; Broussard B; Wan CR; Compton MT
    Psychiatr Q; 2020 Sep; 91(3):769-781. PubMed ID: 32221766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive and negative symptoms in the psychoses: principal components analysis of items from the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms.
    Minas IH; Klimidis S; Stuart GW; Copolov DL; Singh BS
    Compr Psychiatry; 1994; 35(2):135-44. PubMed ID: 8187478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
    J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of untreated psychosis: relationship with baseline characteristics and three-year outcome in first-episode psychosis.
    Chang WC; Tang JY; Hui CL; Lam MM; Wong GH; Chan SK; Chiu CP; Chung DW; Law CW; Tso S; Chan K; Hung SF; Chen EY
    Psychiatry Res; 2012 Aug; 198(3):360-5. PubMed ID: 22425475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and characteristics of individuals with a very long duration of untreated psychosis in an early intervention for psychosis service.
    O'Donoghue B; Lyne J; Kinsella A; Turner N; O'Callaghan E; Clarke M
    Early Interv Psychiatry; 2014 Nov; 8(4):332-9. PubMed ID: 23786447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prospective assessment of the influence of duration of untreated psychosis (DUP) on the course of schizophrenia].
    Cechnicki A; Hanuszkiewicz I; Polczyk R; Bielańska A
    Psychiatr Pol; 2010; 44(3):381-94. PubMed ID: 20672517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Themes of delusions and hallucinations in first-episode psychosis.
    Rajapakse T; Garcia-Rosales A; Weerawardene S; Cotton S; Fraser R
    Early Interv Psychiatry; 2011 Aug; 5(3):254-8. PubMed ID: 21707940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis.
    Fraguas D; Merchán-Naranjo J; del Rey-Mejías Á; Castro-Fornieles J; González-Pinto A; Rapado-Castro M; Pina-Camacho L; Díaz-Caneja CM; Graell M; Otero S; Baeza I; Moreno C; Martínez-Cengotitabengoa M; Rodríguez-Toscano E; Arango C; Parellada M
    Schizophr Res; 2014 Sep; 158(1-3):126-33. PubMed ID: 25034759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.
    Chang WC; Hui CL; Tang JY; Wong GH; Chan SK; Lee EH; Chen EY
    Psychol Med; 2013 Sep; 43(9):1883-93. PubMed ID: 23217676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample.
    Cuesta MJ; Peralta V; Campos MS; Garcia-Jalon E
    Schizophr Res; 2011 Aug; 130(1-3):148-56. PubMed ID: 21632216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.